Creatine

r/Fitness and the Evidence-Based Consensus

In the ecosystem of fitness social media and online communities, creatine occupies a unique position: it is both one of the most heavily myth-surrounded supplements and, simultaneously, one of the few where the online fitness community has arrived at broadly evidence-based consensus. The r/Fitness wiki — a document refined over years by moderators attempting to summarize evidence rather than anecdote — has long recommended creatine monohydrate as one of a small number of supplements with clear, replicable evidence for performance improvement. The recommendation is consistent, confident, and largely correct: creatine works, monohydrate is the form to use, dose is 3–5g per day, timing is mostly irrelevant, expensive alternatives offer no benefit.

This consensus did not emerge from centralized authority — it emerged from years of community experience. Users who tried creatine reported strength improvements; users who stopped creatine (often deliberately in "off-cycles" that have no physiological rationale) reported performance decrements when their muscle creatine stores depleted; the consistency of these reports across thousands of individual experiences matched the clinical trial literature. In a supplement landscape where almost nothing matches the hype, creatine consistently does what the research predicts. This reliability built unusual community credibility over the 2010s and into the 2020s.

The Loading Phase: Ritual Over Rationale

The loading phase — typically 20g daily for 5–7 days, divided into four 5g doses — became standard creatine protocol in gym culture during the late 1990s and early 2000s, derived from the early research protocols that used loading to rapidly saturate muscle creatine stores. The logic is pharmacologically sound: loading reaches saturation in approximately one week, while a consistent 3–5g daily dose reaches the same saturation in approximately four weeks. If you are preparing for a competition or need ergogenic benefit quickly, loading provides faster saturation.

For most recreational users who are not on a competitive timeline, the loading phase is unnecessary — the endpoint (saturated muscle creatine stores) is identical regardless of the path taken to get there. But loading persisted in gym culture for reasons that have little to do with pharmacokinetics: it feels like an intensified intervention, it produces rapid and noticeable weight gain (from water retention associated with elevated muscle creatine), and the 5-day ritual of four-times-daily dosing creates a sense of beginning and commitment. Loading is also what supplement companies recommend on packaging, partly because it depletes the product faster. The evidence that loading is equivalent to a steady maintenance dose for long-term outcomes has been available since the early 2000s and has not displaced the practice.

Water Retention: The Aesthetic Concern That Replaced the Safety Concern

Early public skepticism about creatine ^[1] was primarily about safety — concerns about kidney damage that were eventually disproven across multiple long-term studies in healthy individuals. As the safety evidence accumulated and safety concerns faded, a new concern took their place in the cultural conversation: water retention. Creatine supplementation increases intramuscular water content as elevated creatine stores osmotically draw water into muscle cells. This is not subcutaneous edema (the puffy, soft look associated with sodium-driven water retention) — it is intracellular water stored within muscle fibers, which if anything makes muscles look and feel fuller rather than softer.

Despite this, "creatine makes you bloated" became a persistent concern, particularly among women who were new to strength training and wary of gaining weight. The average body weight increase during creatine loading (1–2kg) is entirely attributable to intramuscular water — not fat, not subcutaneous fluid. But in a culture that conflates scale weight with body composition, a 1–2kg weight increase in the first week of supplementation reads as alarming. The water retention concern has been especially salient in weight-class athletes (wrestlers, fighters, weightlifters) who are managing competition weight. For these athletes, a practical consideration (creatine may add competition weight) was magnified into a general myth that creatine causes water retention problems.

The DHT Panic and Its Single Source

The DHT/hair loss concern is the most culturally persistent creatine myth and the one most easily traced to a specific origin. Van der Merwe, Smith, and Myburgh published a study in Clinical Journal of Sport Medicine in 2009 examining 20 college rugby players randomized to creatine monohydrate or placebo. The study measured serum hormone levels, including DHT (dihydrotestosterone, the androgen implicated in androgenetic alopecia — male pattern baldness). The creatine group showed a significant increase in DHT levels and in the DHT:testosterone ratio during the supplementation period compared to placebo.

This finding was widely reported in fitness media as evidence that creatine causes hair loss. The mechanism seemed plausible: DHT is the androgen that binds to hair follicle receptors in individuals with androgenetic alopecia, accelerating follicle miniaturization. If creatine raises DHT, and DHT causes hair loss, then creatine might accelerate hair loss in genetically predisposed individuals. The logic is coherent. The problem is what the study actually measured, what it did not measure, and what has happened since.

The Van der Merwe study measured DHT levels — it did not measure hair loss. No participant's hair was evaluated. No one was assessed for androgenetic alopecia progression. The study established a surrogate endpoint (hormone level) and implied a clinical endpoint (hair loss) without demonstrating the connection. More critically, the study has never been independently replicated in its finding of a DHT increase with creatine. Multiple subsequent studies examining hormone levels in creatine supplementation — including the ISSN's own review of the hormonal literature — found no significant effect on testosterone, DHT, or the DHT:testosterone ratio. The Van der Merwe result is a statistical outlier in the creatine hormonal literature, not a confirmed finding.

The persistence of the DHT fear despite the failed replication demonstrates how asymmetrically fear-based beliefs resist updating in supplement culture. A 20-person study that measured a surrogate endpoint and was never replicated entered the cultural bloodstream as "creatine causes hair loss," and the evidence base showing no effect has been insufficiently distributed to displace it. For individuals already anxious about hair loss, the possibility of a mechanism — even an unconfirmed, unreplicated one — is sufficient to avoid the supplement. The fear is genuinely impervious to the literature for this population.

The Kidney Concern That Wouldn't Die

Creatine metabolism produces creatinine as a byproduct, and elevated urinary creatinine is used clinically as a biomarker of impaired kidney function. This pharmacological fact — creatine → creatinine — led to early concerns that creatine supplementation would stress the kidneys. Multiple long-term studies have now examined kidney function markers in athletes supplementing creatine for months to years, including studies specifically in individuals with pre-existing kidney conditions. The consensus finding is that creatine supplementation does not impair kidney function in healthy individuals, and the elevated creatinine observed in creatine users is a direct metabolic byproduct rather than a marker of kidney impairment. The American College of Sports Medicine, ISSN, and most major sports nutrition organizations have concluded that creatine is safe for kidney function in healthy individuals. The exception noted in every evidence-based review is individuals with pre-existing kidney disease — in this population, the creatine load may be relevant, and physician consultation is appropriate.

Non-Responders: The Invisible Failure Mode

The most consequential gap in consumer-facing creatine information is the non-responder phenomenon. Approximately 20–30% of individuals who supplement creatine monohydrate at standard doses show minimal increases in intramuscular phosphocreatine stores — and correspondingly minimal performance improvements. These non-responders are not failing to absorb creatine or experiencing some metabolic aberration; they are simply individuals with naturally high baseline muscle creatine levels due to dietary patterns and endogenous synthesis efficiency. Individuals who consume high amounts of red meat and fish already have near-saturated muscle creatine stores. Supplementing these individuals has minimal additional effect because their muscle creatine "tank" is already full.

The implication for trial interpretation is significant. The clinical trials that established creatine's efficacy randomized participants without screening for baseline creatine status. The 20–30% of non-responders in each trial dilute the average effect size — the true effect in genuine responders is larger than the reported trial averages suggest, but trial averages are what gets reported, cited, and translated into consumer expectations. A consumer who expects the average trial effect but happens to be a non-responder will see no benefit and may incorrectly conclude the supplement is ineffective or that they received a counterfeit product.

Identifying non-responders in advance is practically difficult. It requires measuring baseline muscle creatine stores via biopsy or MRS (magnetic resonance spectroscopy) — neither of which is available to consumers. The available proxy is dietary pattern: individuals eating 500g+ of red meat daily are more likely to already have high baseline creatine and thus more likely to be non-responders. Vegetarians and vegans, with zero dietary creatine intake, are reliably high-responders. Omnivores exist on a spectrum. The non-responder phenomenon receives essentially no discussion in supplement marketing, where creatine is presented as universally effective.

Cognitive Benefits: Real But Contextual

The cognitive evidence for creatine is genuine — the mechanism is sound, the trials are credible, the Rawson & Venezia and Avgerinos meta-analyses are methodologically solid. But the magnitude and context-dependence of the cognitive effects are systematically overstated in wellness media. The clearest cognitive benefits occur in three specific populations: vegetarians and vegans (who have below-average brain creatine due to no dietary intake), older adults (who have lower endogenous synthesis and may have accumulated brain creatine deficits), and individuals under acute cognitive stress from sleep deprivation, intense mental workload, or hypoxia. In these populations, creatine supplementation appears to meaningfully improve memory, processing speed, and executive function.

In well-nourished young omnivores at rest — the demographic most actively marketed to for cognitive enhancement — the cognitive benefits of creatine are small to negligible. A healthy 25-year-old eating meat regularly, sleeping adequately, and not under extreme cognitive stress has brain creatine stores near their optimal level. Adding supplemental creatine provides marginal additional substrate for a system that is not constrained. The effect sizes reported in cognitive studies consistently show larger effects in older or dietary-restricted populations than in healthy young omnivores. The nuance — "creatine helps your brain if your brain creatine is relatively low, and may do little if it is already adequate" — is accurate but commercially unattractive. Supplement marketing communicates the positive headline, not the conditional.

The DHT Question: Not Definitively Closed

The Van der Merwe 2009 finding — elevated DHT and DHT:testosterone ratio in creatine-supplementing rugby players — has not been independently replicated, and the weight of the subsequent evidence suggests the finding was a statistical anomaly or result of unknown confounders. However, "not replicated" and "definitively ruled out" are not the same claim. The subsequent studies examining hormone levels in creatine users were not all designed with DHT as a primary endpoint or powered to detect the specific effect Van der Merwe reported. The question of whether creatine modestly increases DHT in some populations under some conditions has not been answered by a adequately powered, pre-registered study designed specifically to test this hypothesis.

For individuals with established androgenetic alopecia who are genetically sensitive to DHT and deeply invested in slowing hair loss progression, the uncertainty is genuinely meaningful. The probability that the Van der Merwe finding reflects a real DHT effect is low based on the accumulated evidence. But a low probability multiplied by a high-stakes personal concern (irreversible hair follicle miniaturization) produces a rational personal decision to avoid creatine, even if the aggregate population-level evidence does not support the hair loss concern. This is a domain where individual risk tolerance and genetics should drive decisions more than population averages.

Adolescent Use: The Under-Studied Population

Creatine supplementation has increased significantly among teenage athletes over the 2010s and 2020s. Survey data from high school sports suggest creatine use prevalence of 10–20% among male athletes in strength sports. The safety evidence base for creatine in adolescents is substantially thinner than in adults — the long-term studies were conducted primarily in adult populations. The ISSN position stand notes that creatine may be appropriate for adolescent athletes meeting specific criteria (competing at an elite level, receiving proper nutrition counseling, with parental oversight), but does not provide the same level of endorsement as for adults.

The theoretical concerns for adolescent use center not on acute toxicity but on long-term effects in developing physiology: whether exogenous creatine might affect endogenous synthesis pathways, alter hormonal development, or interact with the natural anabolic environment of adolescent male development. These concerns are largely theoretical — the trial evidence in adolescents available does not show acute adverse effects — but the long-term data simply does not exist. Pediatric sports medicine organizations are more conservative than adult sports nutrition organizations in their creatine recommendations precisely because the evidence base is thinner and the developmental stakes are higher.

Timing, Form, and the Marketing Premium

Despite the evidence that creatine monohydrate is superior or equivalent to all alternatives, the supplement industry continues to market premium creatine forms (HCl, micronized, buffered) at two to four times the monohydrate price. Micronized creatine is monohydrate with smaller particle size — improved mixing in water, no evidence of performance difference. Creatine HCl is marketed as requiring smaller doses (reducing GI side effects) but has no head-to-head efficacy trial versus monohydrate. Buffered creatine (Kre-Alkalyn) was marketed with the claim that acidic stomach conditions convert creatine to creatinine before absorption; the 2012 trial disproving this did not stop product sales.

The timing evidence is similarly clear: creatine timing relative to workouts has minimal effect on long-term outcomes. A 2013 trial by Antonio and Ciccone in the Journal of the International Society of Sports Nutrition found a modest advantage to post-workout versus pre-workout creatine timing for body composition and strength, but the effect size was small and has not been consistently replicated. The dominant finding across the literature is that total daily dose matters far more than timing. Yet supplement marketing continues to emphasize pre- or post-workout timing as critical, because it integrates creatine into a purchase decision framework (buy the pre-workout or post-workout product stack) rather than treating it as a cheap standalone purchase of a commodity product.